Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Magri

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Scientific Reports|July 14, 2016
Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replicationAndrea Magri, Alexander A Ozerov, Vera L Tunitskaya, et al.
Scientific Reports|August 9, 2020
Pharmacological activation of the circadian component REV-ERB inhibits HIV-1 replicationHelene Borrmann, Rhianna Davies, Matthew Dickinson, et al.
Scientific Reports|August 26, 2016
Corrigendum: Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replicationAndrea Magri, Alexander A Ozerov, Vera L Tunitskaya, et al.
Hepatology (Baltimore, Md.)|February 10, 2018
Resistance analysis of genotype 3 hepatitis C virus indicates subtypes inherently resistant to nonstructural protein 5A inhibitorsDavid Smith, Andrea Magri, David Bonsall, et al.
Iscience|August 3, 2023
Molecular components of the circadian clock regulate HIV-1 replicationHelene Borrmann, Görkem Ulkar, Anna E Kliszczak, et al.
Communications Biology|July 16, 2020
Hypoxic microenvironment shapes HIV-1 replication and latencyXiaodong Zhuang, Isabela Pedroza-Pacheco, Isabel Nawroth, et al.
Viruses|May 28, 2022
Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative DiseaseAndrea Magri, James M Harris, Valentina D'Arienzo, et al.
Frontiers in Immunology|January 3, 2022
A Role for B Cells to Transmit Hepatitis C Virus InfectionIsabelle Desombere, Freya Van Houtte, Ali Farhoudi, et al.
Nature Communications|October 21, 2021
Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failureDavid A Smith, Carlota Fernandez-Antunez, Andrea Magri, et al.
Vaccines|June 25, 2026
Critical Path to First-in-Human Batches of ChAdOx Vectors, Including for Emergency ResponseMarco Polo Peralta Alvarez, Shawkat Hussain, Andrea Magri, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Scientific Reports|July 14, 2016
Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replicationAndrea Magri, Alexander A Ozerov, Vera L Tunitskaya, et al.
Scientific Reports|August 9, 2020
Pharmacological activation of the circadian component REV-ERB inhibits HIV-1 replicationHelene Borrmann, Rhianna Davies, Matthew Dickinson, et al.
Scientific Reports|August 26, 2016
Corrigendum: Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replicationAndrea Magri, Alexander A Ozerov, Vera L Tunitskaya, et al.
Hepatology (Baltimore, Md.)|February 10, 2018
Resistance analysis of genotype 3 hepatitis C virus indicates subtypes inherently resistant to nonstructural protein 5A inhibitorsDavid Smith, Andrea Magri, David Bonsall, et al.
Iscience|August 3, 2023
Molecular components of the circadian clock regulate HIV-1 replicationHelene Borrmann, Görkem Ulkar, Anna E Kliszczak, et al.
Communications Biology|July 16, 2020
Hypoxic microenvironment shapes HIV-1 replication and latencyXiaodong Zhuang, Isabela Pedroza-Pacheco, Isabel Nawroth, et al.
Viruses|May 28, 2022
Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative DiseaseAndrea Magri, James M Harris, Valentina D'Arienzo, et al.
Frontiers in Immunology|January 3, 2022
A Role for B Cells to Transmit Hepatitis C Virus InfectionIsabelle Desombere, Freya Van Houtte, Ali Farhoudi, et al.
Nature Communications|October 21, 2021
Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failureDavid A Smith, Carlota Fernandez-Antunez, Andrea Magri, et al.
Vaccines|June 25, 2026
Critical Path to First-in-Human Batches of ChAdOx Vectors, Including for Emergency ResponseMarco Polo Peralta Alvarez, Shawkat Hussain, Andrea Magri, et al.
Pageof 4